B. Patterson

Epidemiology · Science Translational Medicine · 2008–2019

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 42 citations into it; #1,410 of 2,148 by trust here, #647 by citations
• Endocrinology, Diabetes and Metabolism — 30 citations into it; #373 of 623 by trust here, #223 by citations

Whom B. Patterson trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Klein (in Epidemiology)

Who trusts B. Patterson

1. Gerald I. Shulman (in Epidemiology)
2. V. Samuel (in Epidemiology)

Papers from B. Patterson's perspective

Ordered by how strongly the researchers B. Patterson trusts endorse each paper. Same corpus, a different order for every researcher.

1. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. (New England Journal of Medicine)
2. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. (New England Journal of Medicine)
3. Obesity and Free Fatty Acids (FFA) (Endocrinology and metabolism clinics of North America (Print))
4. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (Journal of Clinical Investigation)
5. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. (Journal of Clinical Investigation)
6. Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans (Diabetes)
7. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action (Nature Medicine)
8. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (Gastroenterology)
9. Abdominal obesity and metabolic syndrome (Nature)
10. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. (Gastroenterology)

Their papers

• Human apoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) — 1,198 citations
• Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. (2019) — 615 citations
• Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. (2016) — 797 citations
• Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) — 998 citations
• Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (2008) — 627 citations